RayzeBio, Inc.
RYZBDelisted Feb 26, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001825367
RayzeBio, Inc. was delisted on Feb 26, 2024; its insiders filed their last Form 4 on Feb 28, 2024; 107 institutions reported holding it in 13F filings for Q4 2023, worth $3.40B in total; superinvestors Viking Global Investors and HHLR Advisors (Hillhouse) held it.
Holders of 5% or more of RYZB
Holders whose latest Schedule 13D or 13G filing reports 5% or more of RayzeBio, Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of RayzeBio, Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
Schedule 13D and 13G filings on RayzeBio, Inc., newest first.
No Schedule 13D or 13G filings on RayzeBio, Inc. are on file.
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell RayzeBio, Inc. shares.
No Form 144 notices for RayzeBio, Inc. are on file.